Advair Diskus

by GlaxoSmithKline (GSK)

Advair Diskus is a widely-used ICS/LABA combination inhaler for asthma and COPD available through the GSK Patient Assistance Program.

What is Advair Diskus?

Advair Diskus (fluticasone propionate/salmeterol) is a combination inhaler containing an inhaled corticosteroid (ICS) and a long-acting beta-agonist (LABA) used twice daily. It is approved for:

  • Maintenance treatment of asthma in adults and children 4 years and older
  • Maintenance treatment of COPD in adults (reducing exacerbations and improving airflow)

Advair Diskus is one of the most widely prescribed respiratory medications. It reduces airway inflammation and keeps bronchial muscles relaxed to prevent asthma attacks and COPD flare-ups.

Patient Assistance Program

Eligible patients may receive Advair Diskus at no cost through the GSK Patient Assistance Program. ClariMeds handles all application paperwork on your behalf.

Eligibility

  • U.S. resident with a valid prescription
  • Uninsured or underinsured
  • Meets household income requirements

Patient assistance programs

GSK Patient Assistance Program

Manufacturer PAP
Eligibility
Uninsured or underinsured U.S. residents with asthma or COPD and a valid Advair Diskus prescription who meet income requirements.
Income limit
Varies based on household size; generally ≤400% of Federal Poverty Level (FPL)
Insurance
Uninsured or underinsured
How to apply
Apply through ClariMeds — we handle all paperwork at no cost to you. Applications are submitted directly to GSK on your behalf.

Need help applying?

ClariMeds handles the entire application process for you — for free. See if you qualify in minutes.

See If You Qualify — Free